Nature's Sunshine Products' Patent-Pending AnxiousLess

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nature's Sunshine Products' Patent-Pending AnxiousLess Formula Indicates Success of New Product Development Strategy

LEHI, Utah, April 23, 2014 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. ("NSP"), a leading natural health and wellness company, launched a new patent-pending formula that addresses "situational anxiety." Nutrition Business Journal's 2013 U.S. Supplement Business Report includes situational anxiety in the category of mood, currently a $507 million business. NSP's unique formula was born of a new two-pronged product development strategy: 1) to generate original intellectual property (IP) through in-house R&D and clinical trials and; 2) to leverage third-party IP to create innovative products that equip NSP distributors with first-mover advantage. NSP introduced the formula in a new product, AnxiousLess, six months ago. Since that launch, AnxiousLess has been so well received by distributors and customers alike that it is already one of NSP's top 10 best-selling products.

"AnxiousLess is a natural, non-drowsy formulation that combines a clinically tested herb ( Sceletium tortuosum ) with additional nutrients often found at the lower end of the normal range in healthy people experiencing occasional anxiety," explained Dr. Matthew Tripp, NSP Chief Scientific Officer.

People experiencing occasional anxiety are believed to exhibit insufficient brain levels of the neurotransmitter serotonin. AnxiousLess helps maintain an environment that maximizes beneficial levels of serotonin signaling to maintain a state of calm in three ways: 1) it increases the amount of serotonin available to receptors, enhancing calming signals; 2) it inhibits an enzyme that blocks serotonin-induced calming messages in the brain; and 3) it provides nutrients essential for nervous system health.

In testing the formulation, NSP found that the combination of Sceletium tortuosum in a specific ratio with L-theanine, zinc, magnesium and vitamin B1 led to a 57% improvement of PDE4 enzyme inhibition (the enzyme that breaks down calming messages to the brain), as opposed to Sceletium alone. This increased inhibition is thought to result in more abundant, longer-lasting calming messages, which would positively impact the user's mood and confidence levels. NSP has filed a provisional patent application on this unique composition. The in-house findings also led Hani Charles Soudah, MD, a board-certified internist practicing in St. Louis, MO, to try the product with a small number of his own patients and measure the effect of AnxiousLess on 10 physiological and psychological parameters associated with situational anxiety. The results showed a persistent decline (indicating reduced anxiousness) across all parameters.

"AnxiousLess has seen very strong uptake in the U.S. market due to our unique formulation supported by clinical research," confirmed Gregory L. Probert, NSP Chairman and Chief Executive Officer. "More than 90% of our sales leaders have purchased the product and we've seen exceptional results in key areas including high sales, low product cannibalization, quick market penetration and sponsoring. We will continue to aggressively implement our new innovative, science-driven product development strategy including ongoing investment in our R&D personnel, equipment and labs."

This investment in clinically researched product offerings will ensure that NSP will continue to be an industry leader as people worldwide take ever-greater responsibility for their health and well-being.

Wynne Roberts, NSP President and Chief Operating Officer added, "Sales leaders are excited to use the product for recruiting purposes because of how well it samples. We received reports that many consumers taking AnxiousLess experienced the product's calming benefit in less than 60 minutes."

Nature's Sunshine Products expects sales will continue to climb as more distributors and customers experience the benefit and business-building potential of this innovative product.

About Nature's Sunshine Products

Nature's Sunshine Products (Nasdaq: NATR ), a leading natural health and wellness company, markets and distributes nutritional and personal care products through a global direct sales force of over 724,000 Independent Managers, Distributors and customers in more than 40 countries. NSP manufactures most of its products through its own state-of-the-art facility to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today. The Company has three reportable business segments that are divided based on the characteristics of their Distributor base, similarities in compensation plans, as well as the internal organization of NSP's officers and their responsibilities (NSP Americas, Asia Pacific and Europe; NSP Russia, Central and Eastern Europe; and Synergy WorldWide). The Company also supports health and wellness for children around the world through its partnership with the Sunshine Heroes Foundation. Additional information about the Company can be obtained at its website, www.natr.com .

Steve Bunker Chief Financial Officer Nature's Sunshine Products, Inc. Lehi, Utah 84043 (801) 341-7303

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rosti Group Expands with Alvi Acquisition

Updated Category News Views 139

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 0

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 98

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 57

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 119

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Bybit Expands On-Chain Access: Japanese Equity Focus

Updated Category News Views 71

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 109

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Biond's BND-67 Trial: New Hope Against Tumors

Updated Category News Views 55

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Continue Reading
Foundayo Aims to Revolutionize Sleep Apnea Treatment

Updated Category News Views 81

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Continue Reading

Top 5 Most Recently Viewed Articles

Sulliden Mining Capital's Annual Meeting Results Unveiled

Updated Category News Views 159

Sulliden Mining Capital's Annual Meeting Results Unveiled On June 30, 2025, Sulliden Mining Capital Inc. (TSX: SMC) held its Annual and Special Meeting of Shareholders. This event followed the guidelines established by the Toronto Stock Exchange. During the meeting, shareholders engaged in an essential process—electing nominees presented in the management information...

Continue Reading
Ascential Medical's Dynamic Leadership Changes for Growth

Updated Category News Views 348

Leadership Changes at Ascential Medical & Life Sciences Ellen Scipta and Chris Cowen are stepping into pivotal roles as CFO and CCO at Ascential Medical & Life Sciences, while Todd Martensen transitions to the role of CSO. These changes reflect the company's commitment to innovation and strategic growth. Introducing Ellen Scipta: New Chief Financial Officer Ellen Scipta...

Continue Reading
Investors Target Xerox Holdings for Securities Class Action

Updated Category News Views 201

Legal Investigation of Xerox Holdings Corporation Faruqi & Faruqi, LLP, a highly regarded national securities law firm, is currently investigating potential claims involving Xerox Holdings Corporation (NASDAQ: XRX). Investors who have suffered significant financial losses are encouraged to reach out to discuss options available to them. Investor Losses and Legal Options...

Continue Reading
Understanding the Risks of Sharing Back-to-School Photos

Updated Category News Views 240

Understanding the Risks of Sharing Back-to-School Photos As families across the nation prepare for a new school year, there’s an important reminder from experienced investigator and child advocate, Moses Castillo. Before sharing those back-to-school photos on social media, it's crucial to consider the potential dangers associated with such posts. The Hidden Dangers of...

Continue Reading
Intel's Journey: Overcoming Two Decades of Market Struggles

Updated Category News Views 111

Intel's Long Road to Recovery Intel has faced significant challenges over the past two decades. Its stock performance has been lackluster, rising only 2% compared to the NASDAQ 100, which has surged over 1,200%. This stark contrast raises questions about Intel's strategic decisions and future direction. Intel's leadership has stumbled in crucial areas that have allowed...

Continue Reading